Bank Of America Corp Geo Vax Labs, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.57 $5 - $9	17 New	17 $0
Q4 2022 Feb 10, 2023	BUY	$0.55 - $17.1 $110 - $3,437	201 Added 744.44%	228 $0
Q3 2022 Nov 14, 2022	BUY	$0.4 - $58.5 $10 - $1,579	27 New	27 $0
Q1 2022 May 16, 2022	SELL	$17.25 - $58.95 $86 - $294	-5 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$52.65 - $71.7 $263 - $358	5 New	5 $0

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $58.1M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.